General Information
Revision date
2019-01-07
Product name
Fosaprepitant Dimeglumine for Injection
Manufacturer Name
Gland Pharma Limited
Icons in SDS
Company Information
company name
Lupin Pharmaceuticals, Inc
Section 2
SECTION 2: Hazards identification
Fire and Explosion Expected to be non-combustible. Health Fosaprepitant is contraindicated in patients: who are hypersensitive to any component of the product. Hypersensitivity reactions including anaphylactic reactions, flushing, erythema, and dyspnea have been reported. taking pimozide. Inhibition of CYP3A4 by aprepitant, the active moiety, could result in elevated plasma concentrations of this drug, which is a CYP3A4 substrate, potentially causing serious or life- threatening reactions, such as QT prolongation, a known adverse reaction of pimozide.
Environmental hazards
No information is available about the potential of this product to produce adverse environmental effects.
